Last Price
0.004
Today's Change
0.00 (0.00%)
Day's Change
0.004 - 0.005
Trading Volume
22,649,117
Market Cap
21 Million
Shares Outstanding
5 Billion
Avg Volume
6,770,081
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
-0.40
EPS
-0.01
Earnings Announcement
03-Feb-2025
Previous Close
0.00
Open
0.00
Day's Range
0.004 - 0.005
Year Range
0.002 - 0.008
Trading Volume
22,649,117
1 Day Change
0.00%
5 Day Change
0.00%
1 Month Change
33.33%
3 Month Change
33.33%
6 Month Change
-20.00%
Ytd Change
-42.86%
1 Year Change
0.00%
3 Year Change
-81.82%
5 Year Change
-83.67%
10 Year Change
-97.71%
Max Change
-99.20%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.